Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05391633 · ClinicalTrials.gov registry record · NA
Maternal Voice and Quantitative EEG (qEEG)
A NA study, sponsored by University of New Mexico.
- Terminated
- Registry status
- NA
- Development phase
- 14
- Enrollment target
NCT05391633 is a NA study that was terminated before completion, run by University of New Mexico. The registered enrollment target is 14 participants.
The verdict
NCT05391633, a NA study, was terminated before completion, sponsored by University of New Mexico.
- TERMINATED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
Study Summary
A short-term randomized, blinded placebo-controlled trial, in premature infants in the neonatal intensive care unit (NICU) at 33-35 weeks post-conceptional age, of recorded maternal voice on quantitative EEG (spectral power density) as a marker of development.
Interventions
- BEHAVIORAL Recorded Maternal Voice
- BEHAVIORAL Placebo Recording
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2022-02-15 |
| Est. Completion | 2024-06-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05391633
The ClinicalTrials.gov registry entry for NCT05391633 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of New Mexico, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Recorded Maternal Voice is the first listed.
NCT05391633 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05391633 about?
NCT05391633 is a clinical study titled "Maternal Voice and Quantitative EEG (qEEG)". A short-term randomized, blinded placebo-controlled trial, in premature infants in the neonatal intensive care unit (NICU) at 33-35 weeks post-conceptional age, of recorded maternal voice on quantitative EEG (spectral power density) as a marker of development.
What is the current status of trial NCT05391633?
This trial is currently terminated. It is a NA study. The enrollment target is 14 participants. The study started on 2022-02-15. Estimated completion is 2024-06-12.
What interventions are being tested in trial NCT05391633?
The interventions under investigation include: Recorded Maternal Voice (BEHAVIORAL), Placebo Recording (BEHAVIORAL).
Who is sponsoring clinical trial NCT05391633?
This trial is sponsored by University of New Mexico, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.